Severe acute respiratory syndrome coronavirus 2 (
SARS-CoV-2) emerged in late 2019 and has since caused a global
pandemic.
Experimental studies and sporadic
reports have confirmed susceptibility of
dogs and
cats to
SARS-CoV-2 infection. However, the importance of
pet animals in the
epidemiology of this
infection is unclear. This study
reports on a first large-scale serosurvey of
SARS-CoV-2 infections in
dogs and
cats in
Europe. From 26 February 2020, just one day after the first confirmed
human case of
SARS-CoV-2 infection in
Croatia, to 15 June 2020,
dog and
cat serum samples were collected from
animals admitted to three
veterinary facilities in
Croatia. Additionally, on 25 May 2020, a total of 122
serum samples from
employees of the
Faculty of
Veterinary Medicine University of Zagreb were collected. Total of 656
dogs and 131
cat serum samples were tested using an in-house microneutralisation test (MNT).
Human serum samples, as well as 172 randomly selected,
dog sera were tested using
enzyme-linked immunosorbent assay (
ELISA).
ELISA-positive
human sera were subsequently tested using MNT. Neutralising
antibodies were confirmed in 0.76%
cats and 0.31%
dogs.
ELISA reactivity was recorded in 7.56% tested
dog sera. On the other
hand, 5.19% of administrative, basic and pre-clinical
sciences department
personnel and 5.13% of
animal health service providers and
laboratory personnel tested
ELISA positive. Neutralising
antibodies were not confirmed in any of the
human samples. In conclusion, seropositivity among
pet animals in
Croatia is low, especially when compared to results from
China. A small number of seropositive
animals with a low titre of neutralising
antibodies suggest
infections are rare and are following
infections in the
human population. Additionally, contact with
animals does not seem to be an
occupational risk for
veterinary practitioners.